Paclitaxel-induced cell-mediated hypersensitivity pneumonitis. Diagnosis using leukocyte migration test, bronchoalveolar lavage and transbronchial lung biopsy

Oncology. 1998 Jul-Aug;55(4):340-4. doi: 10.1159/000011873.

Abstract

A 73-year-old man with mild inactive interstitial pneumonitis and non-small cell bronchogenic carcinoma developed a cell-mediated hypersensitivity pneumonitis within 15 days following a second exposure to paclitaxel. Histological features of transbronchial lung biopsy were consistent with interstitial pneumonitis. Bronchoalveolar lavage showed increased lymphocytes and eosinophils, and decreased helper/suppressor T lymphocyte ratio. Leukocyte migration inhibitory test was positive for paclitaxel. These results support the possibility that paclitaxel-induced pneumonitis is due to delayed type hypersensitivity; they also support the hypothesis of a central role of T lymphocytes in drug-induced pneumonitis.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Antineoplastic Agents, Phytogenic / adverse effects*
  • Biopsy / methods
  • Bronchi
  • Bronchoalveolar Lavage
  • Cell Migration Inhibition
  • Drug Hypersensitivity / etiology*
  • Drug Hypersensitivity / immunology*
  • Humans
  • Immunity, Cellular / drug effects
  • Leukocytes / drug effects*
  • Lung / immunology
  • Lung / pathology
  • Male
  • Paclitaxel / adverse effects*
  • Pneumonia / chemically induced*
  • Pneumonia / immunology*
  • Pneumonia / pathology

Substances

  • Antineoplastic Agents, Phytogenic
  • Paclitaxel